This brand name is authorized in Finland
The drug MALVITONA contains a combination of these active pharmaceutical ingredients (APIs):
1
Caffeine
UNII 3G6A5W338E - CAFFEINE
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
2
Dexpanthenol
UNII 1O6C93RI7Z - DEXPANTHENOL
|
Dexpanthenol is converted in tissues to pantothenic acid, a component of coenzyme A (CoA) that is essential to normal epithelial function, increased fibroblast proliferation and accelerated re-epithelialization in wound healing. |
3
Riboflavin
UNII 957E53WV42 - RIBOFLAVIN 5'-PHOSPHATE SODIUM ANHYDROUS
|
Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth. |
4
Niacinamide
UNII 25X51I8RD4 - NIACINAMIDE
|
|
5
Pyridoxine
UNII 68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE
|
Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition. |
6
Vitamin B1
UNII 8K0I04919X - THIAMINE MONONITRATE
|
Thiamine pyrophosphate (TPP), the coenzymatic form of thiamine, is involved in two main types of metabolic reactions: decarboxylation of α-ketoacids (e.g. pyruvate, α-ketoglutarate and branched-chain keto acids) and transketolation (e.g. among hexose and pentose phosphates). Therefore, the principal physiological role of thiamine is as a coenzyme in carbohydrate metabolism, where TPP is required for several stages in the breakdown of glucose to provide energy. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A11EX | Vitamin B-complex, other combinations | A Alimentary tract and metabolism → A11 Vitamins → A11E Vitamin B-complex, incl. combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 473413 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.